Binding of a thrombin receptor tethered ligand analogue to human platelet thrombin receptor.
A thrombin receptor-radioligand binding assay was developed using [3H]A(pF-F)R(ChA)(hR)Y-NH2 ([3H]haTRAP), a high affinity thrombin receptor-activating peptide (TRAP), and human platelet membranes. Scatchard analysis of saturation binding data indicated that [3H]haTRAP bound to platelet membranes with a Kd of 15 nM and a Bmax of 5.2 pmol/mg of protein. The binding was reduced by GPPNHP, a nonmetabolizable GTP analogue. Various TRAPs and a TRAP antagonist, but not other receptor agonists, displaced [3H]haTRAP from the binding sites. SFLLRN-NH2, a thrombin receptor-tethered ligand analogue, and [3H]haTRAP exhibited competitive binding for the same binding sites. The relative affinity of these peptides for the binding site paralleled their EC50 or IC50 values for platelet aggregation. These data indicate that [3H]haTRAP binds specifically and saturably to the functioning G protein-linked thrombin (tethered ligand) receptor in human platelet membranes.
Ahn
H S
HS
Schering-Plough Research Institute, Kenilworth, NJ 07033, USA. ho-sam.ahn@spcorp.com
Foster
C
C
Boykow
G
G
Arik
L
L
Smith-Torhan
A
A
Hesk
D
D
Chatterjee
M
M
D004305:Dose-Response Relationship, Drug; D006801:Humans; D010446:Peptide Fragments / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D011869:Radioligand Assay; D018179:Receptors, Thrombin / Q000187:drug effects*
D010446:Peptide Fragments; D018179:Receptors, Thrombin; C076901:thrombin receptor-activating peptide (P508-530)